RUA Life Sciences plc (FRA:AOHA)
Germany
· Delayed Price · Currency is EUR 0.0975
0.00 (0.00%)
At close: Dec 4, 2025
RUA Life Sciences Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.57 | 3.93 | 1.48 | 2.96 | 6.29 | Upgrade
|
| Cash & Short-Term Investments | 3.57 | 3.93 | 1.48 | 2.96 | 6.29 | Upgrade
|
| Cash Growth | -9.26% | 164.89% | -49.92% | -52.92% | 218.52% | Upgrade
|
| Accounts Receivable | 1.09 | 0.3 | 0.18 | 0.22 | 0.07 | Upgrade
|
| Other Receivables | - | 0.42 | 0.25 | 0.56 | 0.41 | Upgrade
|
| Receivables | 1.09 | 0.72 | 0.42 | 0.78 | 0.48 | Upgrade
|
| Inventory | 0.75 | 0.11 | 0.08 | 0.12 | 0.09 | Upgrade
|
| Prepaid Expenses | - | 0.23 | 0.17 | 0.34 | 0.47 | Upgrade
|
| Total Current Assets | 5.41 | 4.99 | 2.15 | 4.21 | 7.33 | Upgrade
|
| Property, Plant & Equipment | 3.17 | 2.46 | 2.74 | 2.6 | 1.95 | Upgrade
|
| Goodwill | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | Upgrade
|
| Other Intangible Assets | 0.38 | 0.42 | 0.47 | 0.52 | 0.57 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0 | Upgrade
|
| Total Assets | 9.26 | 8.17 | 5.66 | 7.63 | 10.16 | Upgrade
|
| Accounts Payable | 0.68 | 0.14 | 0.04 | 0.19 | 0.26 | Upgrade
|
| Accrued Expenses | - | 0.22 | 0.2 | 0.15 | 0.28 | Upgrade
|
| Current Portion of Long-Term Debt | 0.23 | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Current Portion of Leases | 0.16 | 0.09 | 0.08 | 0.04 | 0.04 | Upgrade
|
| Current Unearned Revenue | - | 0.03 | 0.05 | 0.04 | 0.02 | Upgrade
|
| Other Current Liabilities | 0.03 | 0.05 | 0.01 | 0.07 | 0.47 | Upgrade
|
| Total Current Liabilities | 1.1 | 0.55 | 0.41 | 0.51 | 1.1 | Upgrade
|
| Long-Term Debt | 0.02 | 0.13 | 0.17 | 0.2 | 0.22 | Upgrade
|
| Long-Term Leases | 0.62 | 0.14 | 0.2 | 0.08 | 0.12 | Upgrade
|
| Long-Term Unearned Revenue | 0.06 | 0.09 | 0.12 | 0.17 | 0.04 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.06 | 0.07 | 0.09 | 0.08 | 0.16 | Upgrade
|
| Total Liabilities | 1.86 | 0.99 | 0.98 | 1.04 | 1.65 | Upgrade
|
| Common Stock | 3.1 | 3.1 | 1.11 | 1.11 | 12.95 | Upgrade
|
| Additional Paid-In Capital | 13.71 | 13.71 | 11.73 | 11.73 | 11.73 | Upgrade
|
| Retained Earnings | -19.98 | -19.99 | -18.55 | -16.54 | -14.48 | Upgrade
|
| Comprehensive Income & Other | 10.47 | 10.36 | 10.39 | 10.29 | -1.7 | Upgrade
|
| Total Common Equity | 7.3 | 7.18 | 4.68 | 6.58 | 8.51 | Upgrade
|
| Minority Interest | 0.09 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 7.39 | 7.18 | 4.68 | 6.58 | 8.51 | Upgrade
|
| Total Liabilities & Equity | 9.26 | 8.17 | 5.66 | 7.63 | 10.16 | Upgrade
|
| Total Debt | 1.03 | 0.39 | 0.48 | 0.34 | 0.41 | Upgrade
|
| Net Cash (Debt) | 2.54 | 3.54 | 1.01 | 2.62 | 5.88 | Upgrade
|
| Net Cash Growth | -28.35% | 251.04% | -61.47% | -55.49% | 197.77% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.11 | 0.05 | 0.12 | 0.33 | Upgrade
|
| Filing Date Shares Outstanding | 62.06 | 62.06 | 22.18 | 22.18 | 22.18 | Upgrade
|
| Total Common Shares Outstanding | 62.06 | 62.06 | 22.18 | 22.18 | 22.18 | Upgrade
|
| Working Capital | 4.31 | 4.44 | 1.74 | 3.7 | 6.23 | Upgrade
|
| Book Value Per Share | 0.12 | 0.12 | 0.21 | 0.30 | 0.38 | Upgrade
|
| Tangible Book Value | 6.62 | 6.46 | 3.91 | 5.76 | 7.63 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | 0.10 | 0.18 | 0.26 | 0.34 | Upgrade
|
| Land | - | 1.34 | 1.34 | 1.34 | 0.94 | Upgrade
|
| Machinery | - | 2.2 | 2.03 | 1.72 | 1.21 | Upgrade
|
| Construction In Progress | - | - | 0.14 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.